Operating Income (Loss) in USD of MAXCYTE, INC. from 2019 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
MAXCYTE, INC. quarterly/annual Operating Income (Loss) history and change rate from 2019 to Q3 2025.
- MAXCYTE, INC. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$14.1M, a 0.68% decline year-over-year.
- MAXCYTE, INC. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$53.6M, a 15.5% decline year-over-year.
- MAXCYTE, INC. annual Operating Income (Loss) for 2024 was -$51.2M, a 6% decline from 2023.
- MAXCYTE, INC. annual Operating Income (Loss) for 2023 was -$48.3M, a 76.5% decline from 2022.
- MAXCYTE, INC. annual Operating Income (Loss) for 2022 was -$27.4M, a 50.4% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)